DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Benicar HCT (Olmesartan / Hydrochlorothiazide) - Adverse Event Reports - Serious Event - Loss of Consciousness

 



Index of reports > Cases resulting in a serious event (20) > Cases with Loss of Consciousness (5)

Below is the selection of adverse event reports related to Benicar HCT (Olmesartan / Hydrochlorothiazide) that includes cases resulting in a serious event where reactions include loss of consciousness.

Adverse event in 55 year old female receiving Benicar HCT (Olmesartan / Hydrochlorothiazide)

Reported by a pharmacist from United States on 2007-05-23

Patient: 55 year old female, weighing 52.2 kg (114.8 pounds)

Adverse reactions / side effects: Blood Pressure Increased, Iron Deficiency Anaemia, Nausea, DRY Mouth, Coma, Hyponatraemia, Loss of Consciousness

Adverse event resulted in: hospitalization

Suspect drug(s):
Benicar HCT
    Indication: Hypertension

Chantix
    Administration route: Oral
    Indication: Smoking Cessation Therapy
    Start date: 2007-03-15
    End date: 2007-03-19

Other drugs received by patient: Prednisone TAB; Plaquenil; Lopressor; Thiamin; Vitamin CAP



Adverse event in 55 year old female receiving Benicar HCT (Olmesartan / Hydrochlorothiazide)

Reported by a pharmacist from United States on 2007-04-23

Patient: 55 year old female, weighing 52.2 kg (114.8 pounds)

Adverse reactions / side effects: Blood Pressure Increased, Iron Deficiency Anaemia, Nausea, DRY Mouth, Coma, Hyponatraemia, Loss of Consciousness

Adverse event resulted in: hospitalization

Suspect drug(s):
Benicar HCT
    Dosage: per oral
    Administration route: Oral
    Indication: Hypertension
    End date: 2007-01-01

Chantix
    Dosage: see image, per oral
    Administration route: Oral
    Indication: Smoking Cessation Therapy
    Start date: 2007-03-08
    End date: 2007-03-10

Chantix
    Dosage: see image, per oral
    Administration route: Oral
    Indication: Smoking Cessation Therapy
    Start date: 2007-03-11
    End date: 2007-03-14

Chantix
    Dosage: see image, per oral
    Administration route: Oral
    Indication: Smoking Cessation Therapy
    Start date: 2007-03-15
    End date: 2007-03-19

Other drugs received by patient: Prednisone (Prednisone) (Prednisone); Plaquenil (Hydroxychloroquine Sulfate) (Hydroxychloroquine Sulfate); Lopressor; Thiamin (Thiamine Hydrochloride) (Thiamine Hydrochloride); Multivitamin



Adverse event in 55 year old female receiving Benicar HCT (Olmesartan / Hydrochlorothiazide)

Reported by a pharmacist from United States on 2007-04-20

Patient: 55 year old female, weighing 52.2 kg (114.8 pounds)

Adverse reactions / side effects: Blood Pressure Increased, Iron Deficiency Anaemia, Nausea, DRY Mouth, Coma, Hyponatraemia, Loss of Consciousness

Adverse event resulted in: hospitalization

Suspect drug(s):
Benicar HCT
    Indication: Hypertension

Chantix
    Administration route: Oral
    Indication: Smoking Cessation Therapy
    Start date: 2007-03-15
    End date: 2007-03-19

Other drugs received by patient: Prednisone TAB; Plaquenil; Lopressor; Thiamin; Vitamin CAP



Adverse event in 54 year old male receiving Benicar HCT (Olmesartan / Hydrochlorothiazide)

Reported by a physician from United States on 2007-03-27

Patient: 54 year old male, weighing 80.7 kg (177.6 pounds)

Adverse reactions / side effects: Cardiac Murmur, Hyperhidrosis, Loss of Consciousness, Ventricular Hypertrophy, Syncope, Dizziness, Hypertension, Asthenia, Blood Magnesium Increased, White Blood Cell Count Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Benicar HCT (Olmesartan / Hydrochlorothiazide)



Adverse event in male receiving Benicar HCT (Olmesartan / Hydrochlorothiazide)

Reported by a physician from United States on 2007-01-22

Patient: male

Adverse reactions / side effects: Loss of Consciousness

Adverse event resulted in: hospitalization

Suspect drug(s):
Benicar HCT (Olmesartan / Hydrochlorothiazide)

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009